Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basalin insulin glargine in adults with type 2 diabetes
IRCT20201230049882N1Phase 4Completed
- Sponsor
- Pooyesh Darou
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluralaner in type 2 diabetes mellitus (T2DM), sponsored by Pooyesh Darou. Primary endpoints: Change in glycated hemoglobin and Change in blood glucose. Started Apr 2021; status: completed.
02
Drugs
fluralaner
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20201230049882N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201230049882N1.